Yue C - Search Results

1

CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways.

Liu X, Chong Y, Tu Y, Liu N, Yue C, Qi Z, Liu H, Yao Y, Liu H, Gao S, Niu M, Yu R. Liu X, et al. Among authors: yue c. J Hematol Oncol. 2016 Oct 12;9(1):108. doi: 10.1186/s13045-016-0338-2. J Hematol Oncol. 2016. PMID: 27733172 Free PMC article.

2

Smoothened is a poor prognosis factor and a potential therapeutic target in glioma.

Tu Y, Niu M, Xie P, Yue C, Liu N, Qi Z, Gao S, Liu H, Shi Q, Yu R, Liu X. Tu Y, et al. Among authors: yue c. Sci Rep. 2017 Feb 14;7:42630. doi: 10.1038/srep42630. Sci Rep. 2017. PMID: 28195165 Free PMC article.

3

FoxR2 promotes glioma proliferation by suppression of the p27 pathway.

Liu X, Liu N, Yue C, Wang D, Qi Z, Tu Y, Zhuang G, Zhou D, Gao S, Niu M, Yu R. Liu X, et al. Among authors: yue c. Oncotarget. 2017 Apr 27;8(34):56255-56266. doi: 10.18632/oncotarget.17447. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915588 Free PMC article.

4

High expression of Bruton's tyrosine kinase (BTK) is required for EGFR-induced NF-κB activation and predicts poor prognosis in human glioma.

Yue C, Niu M, Shan QQ, Zhou T, Tu Y, Xie P, Hua L, Yu R, Liu X. Yue C, et al. J Exp Clin Cancer Res. 2017 Sep 25;36(1):132. doi: 10.1186/s13046-017-0600-7. J Exp Clin Cancer Res. 2017. PMID: 28946903 Free PMC article.

5

The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma.

Liu X, Chen X, Shi L, Shan Q, Cao Q, Yue C, Li H, Li S, Wang J, Gao S, Niu M, Yu R. Liu X, et al. Among authors: yue c. J Exp Clin Cancer Res. 2019 May 23;38(1):219. doi: 10.1186/s13046-019-1235-7. J Exp Clin Cancer Res. 2019. PMID: 31122294 Free PMC article.

6

Inhibition of chromosomal region maintenance 1 suppresses the migration and invasion of glioma cells via inactivation of the STAT3/MMP2 signaling pathway.

Shan Q, Li S, Cao Q, Yue C, Niu M, Chen X, Shi L, Li H, Gao S, Liang J, Yu R, Liu X. Shan Q, et al. Among authors: yue c. Korean J Physiol Pharmacol. 2020 May 1;24(3):193-201. doi: 10.4196/kjpp.2020.24.3.193. Korean J Physiol Pharmacol. 2020. PMID: 32392910 Free PMC article.

7

[No title available]

[No authors listed] [No authors listed] PMID: 32395070

8

MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation.

Liu X, Yue C, Shi L, Liu G, Cao Q, Shan Q, Wang Y, Chen X, Li H, Wang J, Gao S, Niu M, Yu R. Liu X, et al. Among authors: yue c. J Cell Mol Med. 2020 Jul;24(13):7550-7562. doi: 10.1111/jcmm.15383. Epub 2020 May 25. J Cell Mol Med. 2020. PMID: 32452133 Free PMC article.

9

microRNA-4500 inhibits human glioma cell progression by targeting IGF2BP1.

Li ZW, Xue M, Zhu BX, Yue CL, Chen M, Qin HH. Li ZW, et al. Biochem Biophys Res Commun. 2019 Jun 11;513(4):800-806. doi: 10.1016/j.bbrc.2019.04.058. Epub 2019 Apr 16. Biochem Biophys Res Commun. 2019. PMID: 31000197

10

Observation of a rare beta decay of the charmed baryon with a Graph Neural Network.

BESIII Collaboration. BESIII Collaboration. Nat Commun. 2025 Jan 15;16(1):681. doi: 10.1038/s41467-024-55042-y. Nat Commun. 2025. PMID: 39814737 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,723 results

Search Page

Filters